购物车
- 全部删除
- 您的购物车当前为空
Sonlicromanol hydrochloride (KH176 hydrochloride) 是可透过血脑屏障的 ROS-redox 调节剂,具有潜在的抗癌活性, 可改善 iPSC 衍生神经元中与 m.3243A>G 异质相关的神经元网络功能障碍和转录组变化,可用于治疗线粒体疾病。
Sonlicromanol hydrochloride (KH176 hydrochloride) 是可透过血脑屏障的 ROS-redox 调节剂,具有潜在的抗癌活性, 可改善 iPSC 衍生神经元中与 m.3243A>G 异质相关的神经元网络功能障碍和转录组变化,可用于治疗线粒体疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,230 | 现货 | |
5 mg | ¥ 2,970 | 现货 | |
10 mg | ¥ 4,970 | 现货 | |
25 mg | ¥ 7,570 | 现货 | |
50 mg | ¥ 9,870 | 现货 | |
100 mg | ¥ 13,700 | 现货 | |
200 mg | ¥ 18,500 | 现货 |
产品描述 | Sonlicromanol hydrochloride (KH176 hydrochloride) is a ROS-redox modulator that crosses the blood-brain barrier, has potential anticancer activity, improves m.3243A>G heterogeneity in iPSC-derived neurons associated with It has potential anticancer activity, ameliorates neuronal network dysfunction and transcriptomic changes associated with m.3243A>G heterogeneity in iPSC-derived neurons, and can be used for the treatment of mitochondrial diseases. |
体内活性 | 在 Ndufs4−/− 小鼠(利维氏病模型)中,Sonlicromanol hydrochloride(10 mg/kg;腹腔注射,每日一次)显著改善了转筒和步态表现,减少了视网膜神经节细胞的退行性变。此外,导致外囊的FA值显著增加,并且在脑脚盆中显示出类似的趋势[1]。 |
别名 | KH 176 hydrochloride |
分子量 | 368.9 |
分子式 | C19H29ClN2O3 |
CAS No. | 2162149-24-6 |
Smiles | Cl.Cc1c(C)c2O[C@@](C)(CCc2c(C)c1O)C(=O)N[C@@H]1CCCNC1 |
存储 | store under nitrogen,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (406.61 mM), Sonification is recommended. H2O: 80 mg/mL (216.86 mM.) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容